Ensol Biosciences Inc. Logo

Ensol Biosciences Inc.

Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.

140610 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 51(탑립동), 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ensol Biosciences Inc. is a clinical-stage biopharmaceutical company developing innovative drugs for diseases with high unmet medical needs. The company specializes in creating PPI (Protein-Protein Interaction)-regulating short peptide drugs, utilizing a proprietary bio big data and AI platform for discovery and development. Its therapeutic approach focuses on local, non-blood injections to maximize efficacy, ensure high target specificity, and minimize systemic side effects due to a short half-life in the bloodstream. Ensol's clinical pipeline targets conditions such as osteoarthritis, degenerative disc disease, cancer, and Alzheimer's disease. Key candidates include E1K for osteoarthritis (preparing for Phase 3) and C1K, a combination cancer therapy (Phase 1).

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Ensol Biosciences Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ensol Biosciences Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ensol Biosciences Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
DT&CRO CO., Ltd. Logo
A full-service CRO for pharma & biotech, from non-clinical studies to FDA approval support.
South Korea 383930
DUSKIN CO.,LTD. Logo
Franchises cleaning rentals and services for homes and businesses, and operates food chains.
Japan 4665
D.Western Therapeutics Institute, Inc. Logo
Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.
Japan 4576
ECHOMARKETING Co.,Ltd. Logo
Global agency accelerating sales with data-driven, full-funnel digital marketing.
South Korea 230360
Eezy Oyj Logo
HR services firm for the full employment lifecycle, from recruitment to freelancer support.
Finland EEZY
Enjin Co., Ltd. Logo
PR firm for SMEs and medical institutions, offering consulting and a media matching platform.
Japan 7370
Eutilex Co.,Ltd. Logo
Develops T-cell and antibody immunotherapies for cancer and autoimmune diseases.
South Korea 263050
Evogene Ltd. Logo
AI-powered platform designing life-science solutions for health, ag, and industrial sectors.
Israel EVGN
EXACT Therapeutics AS Logo
Biopharma firm using ultrasound to enhance drug delivery for oncology via its ACT® platform.
Norway EXTX
Offers performance-based advertising and CPA solutions via Japan's largest affiliate network.
Japan 2461

Talk to a Data Expert

Have a question? We'll get back to you promptly.